) gained about 8.3% after the company reported its Q1 profit at $131 million, or $0.30 per share, from $23 million, or $0.05 per share, in the year-earlier period. The company's sales increased 5.7% to $5.89 billion. Its same-store sales surged 5.4%. However, analysts were expecting earnings of $0.18 per share. Macy's lifted its full-year same-store sales growth forecast to a rise of around 4.3% from its earlier forecast of a 3% rise. The company raised its profit projections to a range of $2.40 to $2.45 per share, up from its earlier guidance of $2.25 to $2.30 per share. However, analysts were projecting profit of $2.34 per share for the year. The company also increased its quarterly dividend to $0.10 per share. Shares of Teva Pharmaceutical Industries Ltd (NASDAQ:

) gained about 0.8% after the company reported a 6.7% rise in its first-quarter net income. The company also affirmed its projections for the full year. The company's profit increased to $761 million, or $0.84 per share, versus $713 million, or $0.79 per share, in the year-ago period. The company's adjusted net rose to $1.04 per share from $0.91 per share. The company's shares outstanding dropped 2.1% to 902 million. Its sales climbed 12% to $4.08 billion. However, analysts were expecting earnings of $1.04 per share on sales of $4.28 billion. TEVA's sales in Europe increased 66% while sales in North America dropped 11%. TEVA projects 2011 adjusted earnings of $4.90 to $5.20 per share on revenue of $18.5 billion to $19 billion. However, analysts were projecting earnings of $5.07 per share on revenue of $18.74 billion. Read more